DXR · Daxor Corp
Market Cap
$44.52M
Shares
4.20M
Volume · Oct 5
30.32K
Avg daily vol (3M)
18.66K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.63
Open$10.60
Day$10.50–11.07
52W close$8.87–14.75
Avg vol 30d35K
Short int2K · 0.1% float · 1.0d
Short vol23%
Last earningsDec 31, 2024
DataJan 2020–Oct 2026
Up next
call held Dec 31, 2024
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-24.8%
Year over year
Operating margin
-400.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$59,625
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.6%
Year over year · fewer shares
Price change (1Y)
-24.1%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−5%
below
Price vs 50-day avg
−1%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
30%
mid-range
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+8%
trailing
YTD return
−28%
this year
Relative strength
−3%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $11 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.06% of float · ▲ +293.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
15 holders — near 3-yr high, broad support
Squeeze score
44
elevated · 0–100
Fundamentals
Revenue growth
−8%
Y/Y
Gross margin
55%
expanding
Free cash flow
$-6.6M
Quant / Vol
risk profile
Volatility
52%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−5%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
30%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $11 › 200d $11 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.06% of float · ▲ +293.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
15 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9
Now $11 · 30%
Range high $15
vs 200-day avg -5%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DXR
this stock
Daxor Corp
|
$44.52M | -27.9% | -8.4% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$143.14B | -28.2% | +20.5% | 46.5 | 2.3% |
|
BDX
Becton Dickinson & Co
|
$49.57B | — | +8.2% | — | 4.2% |
|
MDLN
Medline Inc.
|
$45.62B | -14.8% | +11.5% | — | 3.1% |
|
RMD
Resmed Inc
|
$32.02B | -7.5% | +13.4% | 21.3 | 9.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DXR | -6.3% | +3.5% | +8.1% | -5.5% | -27.9% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -7.5% | +2.9% | -3.4% | -7.1% | -41.6% |